Uchini Kosgodage
Title
Cited by
Cited by
Year
Blood/plasma secretome and microvesicles
JM Inal, U Kosgodage, S Azam, D Stratton, S Antwi-Baffour, S Lange
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1834 (11), 2317-2325, 2013
882013
Chloramidine/bisindolylmaleimide-I-mediated inhibition of exosome and microvesicle release and enhanced efficacy of cancer chemotherapy
US Kosgodage, RP Trindade, PR Thompson, JM Inal, S Lange
International journal of molecular sciences 18 (5), 1007, 2017
462017
The emerging role of exosome and microvesicle‐(EMV‐) based cancer therapeutics and immunotherapy
C Moore, U Kosgodage, S Lange, JM Inal
International Journal of Cancer 141 (3), 428-436, 2017
432017
Peptidylarginine deiminases—roles in cancer and neurodegeneration and possible avenues for therapeutic intervention via modulation of exosome and microvesicle (EMV) release?
S Lange, M Gallagher, S Kholia, US Kosgodage, M Hristova, J Hardy, ...
International journal of molecular sciences 18 (6), 1196, 2017
312017
Peptidylarginine deiminases post-translationally deiminate prohibitin and modulate extracellular vesicle release and MicroRNAs in glioblastoma multiforme
US Kosgodage, P Uysal-Onganer, A MacLatchy, I Kraev, NP Chatterton, ...
International journal of molecular sciences 20 (1), 103, 2019
242019
Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer
US Kosgodage, R Mould, AB Henley, AV Nunn, GW Guy, EL Thomas, ...
Frontiers in pharmacology 9, 889, 2018
232018
Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitise Bacteria to Antibiotic Treatment
US Kosgodage, P Matewele, G Mastroianni, D Brotherton, B Awamaria, ...
Frontiers in cellular and infection microbiology 9, 227, 2019
172019
Cannabidiol affects extracellular vesicle release, miR21 and miR126, and reduces prohibitin protein in glioblastoma multiforme cells
US Kosgodage, P Uysal-Onganer, A MacLatchy, R Mould, AV Nunn, ...
Translational oncology 12 (3), 513-522, 2019
142019
Cannabidiol is a novel modulator of bacterial membrane vesicles
US Kosgodage, P Matewele, B Awamaria, I Kraev, P Warde, ...
Frontiers in Cellular and Infection Microbiology 9, 324, 2019
82019
Treatment of prostate cancer using deimination antagonists and microvesicle technology
S Lange, S Kholia, US Kosgodage, JM Inal
Protein Deimination in Human Health and Disease, 413-425, 2017
32017
Inhibition of extracellular vesicle release enhances cancer chemotherapy and inhibition of outer membrane vesicle release sensitises bacteria to antibiotic and bacteriophage …
US Kosgodage
London Metropolitan University, 2019
2019
Let us know how access to this document benefits you.
US Kosgodage
2017
Peptidylarginine Deiminases as Mediators of Microvesicular Release-Novel Therapeutic Interventions
S Lange, S Kholia, U Kosgodage, M Hristova, J Hardy, JM Inal
Preprints, 2017
2017
PW1. 04. Inhibitors of microvesicle release with the potential to enhance effectivity of cancer chemotherapy
S Lange, U Kosgodage, JM Inal
Journal of Extracellular Vesicles 5, 34, 2016
2016
PF7. 09 Non-phagocytic epithelial cells take up microvesicles by micropinocytosis
S Lange, U Kosgodage, JM Inal
Journal of Extracellular Vesicles 5, 172, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–15